- Home
- NIU vs LXEO Comparison
NIU vs LXEO Comparison
Compare NIU & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- LXEO
- Stock Information
- Founded
- NIU 2014
- LXEO 2017
- Country
- NIU China
- LXEO United States
- Employees
- NIU N/A
- LXEO N/A
- Industry
- NIU Auto Manufacturing
- LXEO
- Sector
- NIU Consumer Discretionary
- LXEO
- Exchange
- NIU Nasdaq
- LXEO Nasdaq
- Market Cap
- NIU 182.4M
- LXEO 140.6M
- IPO Year
- NIU 2018
- LXEO 2023
- Fundamental
- Price
- NIU $2.56
- LXEO $2.85
- Analyst Decision
- NIU
- LXEO Strong Buy
- Analyst Count
- NIU 0
- LXEO 5
- Target Price
- NIU N/A
- LXEO $23.80
- AVG Volume (30 Days)
- NIU 904.1K
- LXEO 497.8K
- Earning Date
- NIU 03-17-2025
- LXEO 03-18-2025
- Dividend Yield
- NIU N/A
- LXEO N/A
- EPS Growth
- NIU N/A
- LXEO N/A
- EPS
- NIU N/A
- LXEO N/A
- Revenue
- NIU $420,244,416.00
- LXEO N/A
- Revenue This Year
- NIU $16.60
- LXEO N/A
- Revenue Next Year
- NIU $24.42
- LXEO N/A
- P/E Ratio
- NIU N/A
- LXEO N/A
- Revenue Growth
- NIU 5.83
- LXEO N/A
- 52 Week Low
- NIU $1.60
- LXEO $2.32
- 52 Week High
- NIU $3.50
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- NIU 57.01
- LXEO 37.12
- Support Level
- NIU $2.26
- LXEO $2.51
- Resistance Level
- NIU $2.55
- LXEO $2.95
- Average True Range (ATR)
- NIU 0.21
- LXEO 0.33
- MACD
- NIU -0.01
- LXEO 0.07
- Stochastic Oscillator
- NIU 49.21
- LXEO 39.62
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, moped and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.